Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026

Lundbeck announced it will showcase progress in its movement-disorders pipeline at MDS 2026, including data related to multiple system atrophy and Parkinson's disease. The provided text contains no clinical efficacy, safety, financial, regulatory, or commercial details, limiting the immediate market significance.